Oberon Investments - Exercise of Warrants & Total Voting Rights
RNS Number : 7667W
Oberon Investments Group PLC
28 April 2021

Oberon Investments Group PLC

("Oberon Investments" or the "Company")

Exercise of Warrants

and Total Voting Rights

The Company has been informed that warrants over 2,000,000 Ordinary Shares with an exercise price of 2.5p per share have been exercised on 27 April 2021 and application will be made for them to be admitted to trading on AQSE, which is expected to be on or around 04 May 2021.


Following the exercise of these warrants the Company has 11,500,000 shares under warrant, with an exercise price of 7.5p each and which expire on 22 September 2021.

The new Ordinary Shares will rank pari passu with the existing Ordinary Shares of the Company.

Total Voting Rights

Following the exercise of warrants the Company has 409,789,775 Ordinary shares in issue. No Ordinary Shares are held in treasury.

The above figure for total number of Ordinary Shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

This announcement contains information which, prior to its disclosure, was inside information as stipulated under Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310 (as amended). 


The Directors of the Company take responsibility for this announcement.


Oberon Investments Group Plc


Simon McGivern / John Beaumont





Via Walbrook PR

AQSE Corporate Adviser

Novum Securities Limited


Richard Potts / Daphne Zhang / Lucy Bowden

020 7399 9400

Walbrook PR Ltd


Tom Cooper / Nick Rome


Tel: 020 7933 8780 or oberon@walbrookpr.com





This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.